menu
Your Cart

ITT0317

ITT0317-2
ITT0317
ITT0317-2
ITT0317
ITT0317
  • Catalog: ITT0317
  • Gene/Protein: ARHGAP18
  • Product Description: Immunotag™ ARHGAP18 Polyclonal Antibody
385.0000
Price in reward points: 385

Available Options

Immunotag™ ARHGAP18 Polyclonal Antibody
Antibody Specification
Datasheet
Target Protein ARHGAP18
Clonality Polyclonal
Storage/Stability -20°C/1 year
Application WB,IHC-p,ELISA
Recommended Dilution Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. ELISA: 1/40000. Not yet tested in other applications.
Concentration 1 mg/ml
Reactive Species Human
Host Species Rabbit
Immunogen The antiserum was produced against synthesized peptide derived from human RHG18. AA range:517-566
Specificity ARHGAP18 Polyclonal Antibody detects endogenous levels of ARHGAP18 protein.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
Form Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Gene Name ARHGAP18
Accession No. Q8N392 Q8K0Q5
Alternate Names ARHGAP18; Rho GTPase-activating protein 18; MacGAP; Rho-type GTPase-activating protein 18
Description Rho GTPase activating protein 18(ARHGAP18) Homo sapiens ARHGAP18 belongs to a family of Rho (see MIM 165390) GTPase-activating proteins that modulate cell signaling (Potkin et al., 2009 [PubMed 19065146]).[supplied by OMIM, Apr 2010],
Protein Expression Brain,Mast cell,Melanoma,Uterus,
Subcellular Localization cytoplasm,cytosol,cell-cell adherens junction,
Protein Function function:GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state.,sequence caution:Contaminating sequence. Potential poly-A sequence.,similarity:Contains 1 Rho-GAP domain.,subunit:Interacts with MPHOSPH6.,
Usage For Research Use Only! Not for diagnostic or therapeutic procedures.
Material Safety Data Sheet
English_US
Danish
Dutch
English_UK
French
German
Spanish
Norwegian
Portuguese
Finnish
Swedish
Polish

Write a review

Note: HTML is not translated!
Bad Good
Captcha

CONNECT WITH US